These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19582526)

  • 1. Successful spinal fusion by E. coli-derived BMP-2-adsorbed porous beta-TCP granules: a pilot study.
    Dohzono S; Imai Y; Nakamura H; Wakitani S; Takaoka K
    Clin Orthop Relat Res; 2009 Dec; 467(12):3206-12. PubMed ID: 19582526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lumbar spinal fusion with β-TCP granules and variable Escherichia coli-derived rhBMP-2 dose.
    Pelletier MH; Oliver RA; Christou C; Yu Y; Bertollo N; Irie H; Walsh WR
    Spine J; 2014 Aug; 14(8):1758-68. PubMed ID: 24486479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterolateral lumbar fusion using Escherichia coli-derived rhBMP-2/hydroxyapatite in the mini pig.
    Kong CB; Lee JH; Baek HR; Lee CK; Chang BS
    Spine J; 2014 Dec; 14(12):2959-67. PubMed ID: 24937799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
    Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
    Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
    Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
    Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
    Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model.
    Liao SS; Guan K; Cui FZ; Shi SS; Sun TS
    Spine (Phila Pa 1976); 2003 Sep; 28(17):1954-60. PubMed ID: 12973141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
    Kai T; Shao-qing G; Geng-ting D
    Spine (Phila Pa 1976); 2003 Aug; 28(15):1653-8. PubMed ID: 12897487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled delivery of low-dose bone morphogenetic protein-2 using heparin-conjugated fibrin in the posterolateral lumbar fusion of rabbits.
    Koo KH; Lee JM; Ahn JM; Kim BS; La WG; Kim CS; Im GI
    Artif Organs; 2013 May; 37(5):487-94. PubMed ID: 23461810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of interspinous process lumbar fusion with recombinant human bone morphogenetic protein-2 delivered with a synthetic polymer and β-tricalcium phosphate in a rabbit model.
    Matsumoto T; Toyoda H; Dohzono S; Yasuda H; Wakitani S; Nakamura H; Takaoka K
    Eur Spine J; 2012 Jul; 21(7):1338-45. PubMed ID: 22203476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion performance of low-dose recombinant human bone morphogenetic protein 2 and bone marrow-derived multipotent stromal cells in biodegradable scaffolds: a comparative study in a large animal model of anterior lumbar interbody fusion.
    Abbah SA; Lam CX; Ramruttun AK; Goh JC; Wong HK
    Spine (Phila Pa 1976); 2011 Oct; 36(21):1752-9. PubMed ID: 21673630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers.
    David SM; Gruber HE; Meyer RA; Murakami T; Tabor OB; Howard BA; Wozney JM; Hanley EN
    Spine (Phila Pa 1976); 1999 Oct; 24(19):1973-9. PubMed ID: 10528370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
    Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
    J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-intensity pulsed ultrasound enhances posterior spinal fusion implanted with mesenchymal stem cells-calcium phosphate composite without bone grafting.
    Hui CF; Chan CW; Yeung HY; Lee KM; Qin L; Li G; Leung KS; Hu YY; Cheng JC
    Spine (Phila Pa 1976); 2011 Jun; 36(13):1010-6. PubMed ID: 21325987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli-derived BMP-2-absorbed β-TCP granules induce bone regeneration in rabbit critical-sized femoral segmental defects.
    Kuroiwa Y; Niikura T; Lee SY; Oe K; Iwakura T; Fukui T; Matsumoto T; Matsushita T; Nishida K; Kuroda R
    Int Orthop; 2019 May; 43(5):1247-1253. PubMed ID: 30097727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
    Boden SD; Kang J; Sandhu H; Heller JG
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species.
    Boden SD; Schimandle JH; Hutton WC
    Spine (Phila Pa 1976); 1995 Dec; 20(24):2633-44. PubMed ID: 8747241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strut allograft union and remodeling using rhBMP-2 in a spinal corpectomy model.
    White KK; Bawa M; Ahn JS; Farnsworth CL; Faro FD; Mahar AT; Wedemeyer M; Garfin SR; Newton PO
    Spine (Phila Pa 1976); 2005 Jun; 30(12):1386-95. PubMed ID: 15959367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
    Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
    Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.